These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 582696)

  • 21. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum.
    Palnitkar SS; Bin B; Jimenez LS; Morimoto H; Williams PG; Paul-Pletzer K; Parness J
    J Med Chem; 1999 Jun; 42(11):1872-80. PubMed ID: 10354395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of dantrolene sodium and other skeletal muscle relaxants with the Straub tail mouse.
    Ellis KO; Carpenter JF
    Neuropharmacology; 1974 Mar; 13(3):211-4. PubMed ID: 4840845
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the monitoring of neuromuscular blockade during anaesthesia (author's transl)].
    Schuh FT
    Anaesthesist; 1977 Mar; 26(3):107-15. PubMed ID: 857689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural probes for cholinergic sites: L-bebeerine actions on the neuromuscular transmission, the nicotinic receptor/ionic channel complex, and contraction of skeletal muscles.
    Souccar C; Borrás MR; Corrado AP; Lima-Landman MT; Lapa AJ
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):268-78. PubMed ID: 10797870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the new centrally acting muscle relaxant 7-chloro-N,N,3-trimethylbenzo[b]furan-2-carboxamide on motor and central nervous systems in rats.
    Ono H; Saito K; Kondo M; Morishita S; Kato K; Hasebe Y; Nakayama M; Kato F; Nakamura T; Satoh M
    Arzneimittelforschung; 1990 Jul; 40(7):730-5. PubMed ID: 2222548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavior of long-term dantrolene sodium-treated rat skeletal muscles. Histochemical and electromechanical aspects.
    Aoki-Maki K; Cortes-Arroyo AR; Baltazares-Lipp E
    Arch Med Res; 1996; 27(1):63-6. PubMed ID: 8867369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of diazepam on the dosage of muscel-relaxants during anaesthesia.
    Martins HF
    Anaesthesist; 1975 Jan; 24(1):1-5. PubMed ID: 165742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant.
    Ellis KO; Carpenter JF
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(1):83-94. PubMed ID: 4344329
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of 4'fluoro-3-(1-piperidyl) propiophenone (compound CN), a new centrally acting skeletal muscle relaxant.
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):397-400. PubMed ID: 489070
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological profile of N-(2,6-DIMETHYLPHENYL)-N-(1-methyl-2pyrrolidinylidene)urea, xilobam, a new centrally acting skeletal muscle relaxant.
    Gardocki JF; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):326-42. PubMed ID: 99099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-[[[5-(substituted phenyl)-2-oxazolyl]methylene]amino]-2,4- imidazolidinediones, a new class of skeletal muscle relaxants.
    White RL; Wessels FL; Schwan TJ; Ellis KO
    J Med Chem; 1987 Feb; 30(2):263-6. PubMed ID: 3806610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacology of ambenoxan (2-(3',6'-dioxaheptyl)-aminomethyl-1:4-benzodioxane), a centrally acting muscle relaxant.
    Shapero M; Southgate PJ
    Br J Pharmacol; 1970 Feb; 38(2):263-70. PubMed ID: 4313800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice.
    Nevins ME; Nash SA; Beardsley PM
    Psychopharmacology (Berl); 1993; 110(1-2):92-6. PubMed ID: 7870904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [STUDIES ON MUSCLE RELAXANTS AND THEIR ANTAGONISTS. IV. THE MECHANISM OF ACTION OF DIPHENYLAMINOETHYLGUANIDINE AS A SKELETAL MUSCLE RELAXANT].
    OZAWA H; TAKEDA M
    Yakugaku Zasshi; 1965 Jun; 85():539-43. PubMed ID: 14343313
    [No Abstract]   [Full Text] [Related]  

  • 38. Muscle relaxant activity of methocarbamol enantiomers in mice.
    Souri E; Sharifzadeh M; Farsam H; Gharavi N
    J Pharm Pharmacol; 1999 Jul; 51(7):853-5. PubMed ID: 10467962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of drugs which stimulate skeletal muscle and of their antagonists on flux of calcium, potassium and sodium ions.
    AHMAD K; LEWIS JJ
    J Pharmacol Exp Ther; 1962 Jun; 136():298-304. PubMed ID: 13859732
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of centrally acting muscle relaxants on the morphine-induced Straub tail reaction in mice.
    Kameyama T; Ukai M
    Chem Pharm Bull (Tokyo); 1979 May; 27(5):1063-8. PubMed ID: 498368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.